Our R&D Team

Learn more about the backgrounds, scientific pursuits and personal interests of members of our R&D team. These individuals are committed to pursuing Bristol Myers Squibb’s goal of discovering, developing and delivering transformational medicines to patients.

Beatrice Anduze-Faris, M.D.

Vice President, Global Clinical Compliance & Continuous Improvement (GCC&CI), Global Development Operations, Central New Jersey

Michaela Bowden

Director, Translational Biology

Cynthia Brogdon, RN, Ph.D.

Head, Oncology Portfolio Strategy, Oncology Medical

Miranda Broz, Ph.D.

Scientific Associate Director, Discovery Myeloid Biology, Tumor Microenvironment Thematic Research Center, Redwood City, CA 

Edgar Charles, M.D.

Clinical Development Lead, Fibrosis R&D, Central New Jersey

Ho Sung Cho, Ph.D.

Senior Vice President, Discovery Biotherapeutics, San Diego, CA

Sharon Cload, Ph. D.

Vice President, Molecular Discovery Technologies

Elizabeth (Liz) Colston, M.D., Ph.D.

Clinical Development Lead, Dermatology

Myrtle Davis, DVM, Ph.D.

Executive Director, Discovery Toxicology, Central New Jersey

Justine Dell’Aringa

Associate Director, Translational Medicine, Immuno-Oncology & Cell Therapy, Seattle, WA

Binodh DeSilva, Ph.D.

Vice President, Lead, Discovery and Optimization, Small Molecule Drug Discovery, Central New Jersey

Teresa (Teri) Foy, Ph.D.

Senior Vice President, Research and Early Development Immuno-Oncology and Cell Therapy

David Gordon, Ph.D.

Vice President, Cardiovascular and Fibrosis Discovery Biology, Central New Jersey 


Josh Hansen, Ph.D.

Director, Chemistry, San Diego, CA

 Mary Beth Harler, M.D. 

Senior Vice President, Head of Immunology & Fibrosis Development, Global Drug Development,  Princeton, New Jersey 

Melissa Harris, B.Sc, PharmD

Vice President and Head of Fibrosis Development, Central New Jersey

Kristen M. Hege, M.D.

Senior Vice President, Early Clinical Development, Oncology/Hematology and Cell Therapy 

Evan Janovitz

Director of Pathology, Discovery Toxicology , Central New Jersey

Debbie Law (DPhil)

Senior Vice President, Head, Tumor Microenvironment Thematic Research Center, Redwood City, California

Emma Lees, Ph.D.

Vice President, & Site Head of R&D, Oncology Discovery, Cambridge, MA

Michael May, Ph.D.

Countrywide Medical Director, Germany, Global Medical

Ryan Moslin, Ph.D.

Senior Research Investigator, Early Immunology Discovery, Central New Jersey

Saumya Pant, Ph.D.

Director, Clinical Genomics & Genetics, Central New Jersey

Robert Plenge, M.D., Ph.D.

Senior Vice President and Head, Immunology, Cardiovascular and Fibrosis Thematic Research Center; Head, Translational Medicine

Mark Rolfe, Ph.D.

Senior Vice President, Oncogenesis Thematic Research Center

Joseph Szustakowski, Ph.D.

Executive Director, Translational Bioinformatics

John Throup, BSc, Ph.D.

Senior Vice President and Head, Immunology, Cardiovascular, Fibrosis and Global Health Thematic Research Center 

Ruth Wexler, Ph.D.

Vice President, Cardiovascular and Fibrosis Chemistry, Central New Jersey